Jane Skjoeth-Rasmussen

Department of Neurosurgery, Rigshospitalet, Copenhagen University Hospital, Denmark

Disclosure: Nothing to disclose

Presentation(s):

• ATIM-01 - Nivolumab and bevacizumab for recurrent glioblastoma; a translational trial in progress

  Saturday, November 23
  5:00 PM – 7:00 PM

• EPID-06 - Immune-related plasma biomarkers in glioblastoma

  Saturday, November 23
  5:08 PM – 5:12 PM